# A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy

Study · id `cardio:ct-nct03834207` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03834207](<https://clinicaltrials.gov/study/NCT03834207>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03834207

Browse, organ or system: Heart; Metabolism  
Browse, condition area: Heart failure; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 672 participants.

## Technical summary

Registry record NCT03834207. Allocation not applicable; no masking; primary purpose other. Start 2018-10-01 (actual); primary completion 2020-01-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 672 participants (planned count; ClinicalTrials.gov record NCT03834207, source copy `cardio:ctgov-nct03834207-2019-02-07`, retrieved 2026-10-26)
- Started: 2018-10-01 (actual) (ClinicalTrials.gov record NCT03834207, source copy `cardio:ctgov-nct03834207-2019-02-07`, retrieved 2026-10-26)
- Primary completion: 2020-01-31 (anticipated) (ClinicalTrials.gov record NCT03834207, source copy `cardio:ctgov-nct03834207-2019-02-07`, retrieved 2026-10-26)
- Completion: 2020-04-30 (anticipated) (ClinicalTrials.gov record NCT03834207, source copy `cardio:ctgov-nct03834207-2019-02-07`, retrieved 2026-10-26)
- Countries: Spain; Sweden; United Kingdom (ClinicalTrials.gov record NCT03834207, source copy `cardio:ctgov-nct03834207-2019-02-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03834207-2019-02-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study of the Usefulness & Usability of a Healthcare IT System for Managing Multi-morbidity and Poly-pharmacy
- Acronym: C3-Cloud
- Condition: Diabetes Type 2
- Condition: Renal Failure
- Condition: Heart Failure
- Condition: Depression
- Condition: Chronic Disease
- Condition: Aging
- Intervention (Device): Use of the C3-Cloud IT system
- Lead sponsor: Dr Christopher Marguerie
- Lead sponsor class: OTHER
- Collaborator: University of Warwick
- Collaborator class: OTHER
- Collaborator: Biosistemak Institute for Health Systems Research
- Collaborator class: OTHER
- Collaborator: Medixine
- Collaborator class: UNKNOWN
- Collaborator: SRDC
- Collaborator class: UNKNOWN
- Collaborator: Institut National de la Santé Et de la Recherche Médicale, France
- Collaborator class: OTHER\_GOV
- Collaborator: Eurorec
- Collaborator class: UNKNOWN
- Collaborator: Empirica
- Collaborator class: UNKNOWN
- Collaborator: Örebro University, Sweden
- Collaborator class: OTHER
- Collaborator: Osakidetza
- Collaborator class: OTHER
- Collaborator: Region Jämtland Härjedalen
- Collaborator class: OTHER
- Collaborator: Cambio Healthcare
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as a collaborator: University of Warwick (`cardio:org-university-of-warwick`)
- Registry lists this organization as a collaborator: Institut National de la Santé Et de la Recherche Médicale, France (`cardio:org-institut-national-de-la-sante-et-de-la-recherche-medicale-3ba447`)

## Provenance

Content hash: f3a5c45c56edd675e45a0db7734ed81863b9fb3533b714b20fe9a8aa6197cfd6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
